Optimizing Adoptive Cell Immunotherapeutics Via GPS
Robert Sackstein, M.D., discusses the next steps in immunotherapy and how improved delivery of vascularly administered, culture-expanded immune effector cells (e.g., CAR T-cells) can be achieved.
Hematologists, oncologists, pathologists, radiation oncologists, oncology/hematology nurses, nurse practitioners, physician assistants, palliative care staff, pharmacists and other allied health care team members interested in the treatment of patients with hematologic malignancies.
- Identify the molecular basis of cell migration.
- Illustrate how site-specific migration cells can be achieved for adoptive immunotherapy applications.
- Explain how to execute improved site-specific cell trafficking, yielding higher efficacy, safer outcomes and lower costs for adoptive immunotherapy applications.
The Continuing Medical Education Department gratefully acknowledges the following Corporate Philanthropy Partners member of Baptist Health Foundation for providing support of high quality unbiased continuing medical education at the Immunotherapy Symposium, at which the content for this online activity was recorded.
Robert Sackstein, M.D.
Interim Chair, Department of Translational Medicine
Dean and Senior Vice President for Health Affairs, and Professor
Florida International University
Robert Sackstein, M.D., faculty for this educational activity, has indicated that he is a consultant with Biotechne/R&D Systems and Mesoblast Ltd., and he has licenses with Warrior Therapeutics LLC, Mesoblast Ltd., and Biotechne/R&D Systems. He also has equity with Warrior Therapeutics, LLC. He will not include off-label or unapproved product usage in his presentation or discussion.
All of the relevant financial relationships listed for this individual has been mitigated.
This online course is a highlight from the Inaugural Miami Cancer Institute Immunotherapies Summit.
Guenther Koehne, M.D., Ph.D.
Deputy Director of Miami Cancer Institute
Chief of Blood & Marrow Transplant and Hematologic Oncology
Miami Cancer Institute
Guenther Koehne, M.D., Ph.D., conference director for this educational activity, has no relevant financial relationship with ineligible companies* to disclose.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.